Valeant (VRX) Acquires Podiatry-Focused Co. Pedinol Pharmacal
Tweet
Share
E-mail
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) has acquired Pedinol Pharmacal, Inc., a podiatry-focused, privately-owned specialty pharmaceutical company based in the U.S., for less than 1.5 times sales.
Revenue for 2011 was approximately $18 million and the transaction is expected to be immediately accretive.
Revenue for 2011 was approximately $18 million and the transaction is expected to be immediately accretive.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- Mavis acquires Pep Boys from Icahn Enterprises for $700M
- CoStar Group acquires Zonda for $800M, adding new home data
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
